patent blue violet (patent blue V)

Subscribe to Selected New Research on patent blue violet

71 relevant articles (0 outcomes, 5 trials/studies) found for this Bio-Agent

Description: widely used to visualize lymph vessels for lymphography; structure

Also Known As:

patent blue V; (4-(alpha-(p-(diethylamino)phenyl)-2,4-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium hydroxide inner salt sodium salt; Blue URS; Blue VRS; C.I. acid blue 1; acid blue 1; alphazurine 2G; bleu patent V; blue patent violet; disulfine blue; disulphine blue; sulfan blue; sulphan blue; N-(4-((4-(diethylamino)phenyl)(2,4-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethylethanaminium, hydroxide, inner salt, sodium salt

Bio-Agent Context: Research Results

Organic Chemicals: 40

Amines: 1233

Aniline Compounds: 3

Rosaniline Dyes: 68

patent blue violet: 71

Experts

1.	Delaloye, Jean-François: 1 article (09/2008)
2.	Jaffer, Usman: 1 article (09/2008)
3.	Zuber, Jean-Philippe: 1 article (09/2008)
4.	Abdullah, Thofikl I: 1 article (09/2008)
5.	Thierrin, Laurent: 1 article (09/2008)
6.	Spertini, François: 1 article (09/2008)
7.	Steiger, Daniel: 1 article (09/2008)
8.	Brunisholz, Yves: 1 article (09/2008)
9.	Badri, Hassan: 1 article (09/2008)
10.	Resin Geyer, G: 1 article (02/2008)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 03/01/2005 - "Patent blue vital (patent blue V; Laboratoire Guerbet, France) is used to identify the sentinel node during surgery for invasive breast cancer" 01/01/2005 - "823 breast cancer patients underwent SNB based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 99 mTc-nanocolloid and Patent Blue V injected peritumourally" 07/01/2004 - "A total of 618 breast cancer patients underwent SLN biopsy based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 99mTc-nanocolloid and Patent Blue V injected peritumourally" 07/01/2001 - "METHODS: In a consecutive series of 256 patients with primary breast cancer, sentinel node biopsy was performed based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 10 mCi (370 MBq) (99m)Tc-nanocolloid injected peritumorally and 0.5 to 1.0 mL Patent Blue V injected intradermally" 06/01/2000 - "A total of 40 patients (mean age 51 yrs; 36-89 yrs) with clinically T1-T2(< 3 cm)N0M0 breast cancer underwent sentinel node (SN) mapping with radioactive tracer (99mTc) injection only in 21 patients, with Patent blue V in 1 patient, or with both techniques in 19 patients" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 05/01/2008 - "BACKGROUND: Patent Blue V is an inert dye increasingly being used during cancer surgery to identify the sentinel lymph node" 11/01/2007 - "The day of the intervention, 2.5% patent blue V dye (S.A.L.F: Italy) was injected circumferentially around the tumor" 09/01/2007 - "Before resection, 2 to 3 ml of Patent Blue V dye was injected subserosally around the tumor" 11/01/2005 - "METHODS: A total of 56 open colorectal resections were performed, and Patent Blue V dye was injected under the serosa surrounding the tumor immediately after opening the abdomen" 07/01/2004 - "The patent blue V was injected around the tumor before beginning surgery" Get all the results and reference details, order at left...
3.	Carcinoma (Carcinomatosis) 08/01/2004 - "AIM: The aim of this study was to evaluate the use of Patent Blue V for identification of the sentinel node in patients with colon carcinoma" 09/01/2006 - "CONCLUSIONS: The SLN concept in colon carcinoma using Patent Blue V is feasible and accurate" 12/01/2005 - "Patent blue V is a well-known dye for visualisation of the lymph nodes in a sentinel lymph node biopsy in breast carcinoma" 08/01/2004 - "METHOD: From May 2002, 35 patients operated for colon carcinoma underwent lymphatic mapping using Patent Blue V as marker" 08/01/2004 - "Successful sentinel node identification in colon carcinoma using Patent Blue V." Get all the results and reference details, order at left...
4.	Endometrial Neoplasms (Endometrial Cancer) 01/01/2002 - "METHODS AND MATERIALS: In 25 cases of endometrial cancer, patent blue-V was injected into the subserosal myometrium (13 cases, SM group) or cervico-subserosal myometrium (12 cases, CSM group) during a surgical staging procedure" 01/01/2001 - "METHODS AND MATERIALS: In eight cases of early endometrial cancer, patent blue-V was injected laparoscopically into the uterine wall during a surgical staging procedure" 09/01/2003 - "The aim of our study was to determine the feasibility of lymphatic mapping with both labelled colloid and patent blue violet in patients with early stage endometrial cancer" Get all the results and reference details, order at left...
5.	Confusion (Bewilderment) 09/01/1975 - "Because of confusion in the literature, studies were performed on several samples of patent blue violet and Alphazurine 2G to determine their chemical structure and purity" Get all the results and reference details, order at left...
33 Diseases and 71 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	patent blue violet (patent blue V)
2.	Colloids (Colloid)
3.	Dextrans (Dextran)
4.	Methylene Blue (Methylthioninium Chloride)
5.	iso-sulfan blue (Lymphazurin)
6.	Polymethyl Methacrylate (Sol)
7.	Dinoprostone (PGE2)
8.	Tin
9.	Tetracycline (Achromycin)
10.	Technetium Tc 99m Aggregated Albumin
16 Drugs and Important Bio-Agents and 17 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Hysterectomy
2.	Transplants (Transplant)
3.	Resuscitation
4.	Ligation
5.	Laparotomy
6 Therapies and Procedures and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>